Autologous T-reg cell therapy (Tract Therapeutics)
自体调节性T细胞疗法
Report date: 2022/07/19 16:22:54
Base Information
Drug NameAutologous T-reg cell therapy (Tract Therapeutics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTract Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNorthwestern University
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksWikipedia